Genzyme, Apple, Royal Worcester: Intellectual Property

July 26, 2012

By Victoria Slind-Flor

Shelbyzyme LLC, the owner of a patent used to treat organ-destroying Fabry disease, won $50 million from Genzyme Corp. after a jury trial.

Shelbyzyme filed the infringement suit in federal court in Delaware in October 2009.  

This article may be found in its entirety on the Bloomberg Businessweek website.